Literature DB >> 17016445

Chaperoning of estrogen receptor and induction of mammary gland proliferation by neuronal protein synuclein gamma.

Y E Liu1, W Pu, Y Jiang, D Shi, R Dackour, Y E Shi.   

Abstract

Synucleins are emerging as central players in the formation of pathologically insoluble deposits characteristic of neurodegenerative diseases. However, synuclein gamma (SNCG), previously identified as a breast cancer specific gene (BCSG1), is also highly associated with breast cancer progression. Using transgenic mouse model, we demonstrated a role of SNCG in induction of highly proliferative pregnancy-like phenotype of mammary epithelial cells and branching morphology. SNCG participated in the heat shock protein-based multiprotein chaperone complex for steroid receptor signaling. Expression of SNCG in mammary epithelium resulted in a significant stimulation of ERalpha transcriptional activity. SNCG-induced mammary gland proliferation can be effectively blocked by antiestrogen and ovariectomy, indicating that the induced proliferation is mediated by ERalpha signaling and requires estrogen stimulation. These data indicate the chaperone activity of SNCG on stimulation of steroid receptor signaling in mammary gland and, thus induces extensive mammary gland proliferation and contributes to the hormonal impact on mammary tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016445     DOI: 10.1038/sj.onc.1210000

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Expression of gamma-synuclein in colorectal cancer tissues and its role on colorectal cancer cell line HCT116.

Authors:  Qing Ye; Bo Feng; Yuan-Fei Peng; Xue-Hua Chen; Qu Cai; Bei-Qin Yu; Liang-Hui Li; Ming-Yuan Qiu; Bing-Ya Liu; Min-Hua Zheng
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

2.  Synuclein gamma stimulates membrane-initiated estrogen signaling by chaperoning estrogen receptor (ER)-alpha36, a variant of ER-alpha.

Authors:  Yuenian Eric Shi; Yiding Chen; Raduwan Dackour; Louis Potters; Shui Wang; Qiang Ding; Zhaoyi Wang; Yiliang Ellie Liu
Journal:  Am J Pathol       Date:  2010-07-01       Impact factor: 4.307

3.  Synuclein gamma protects HER2 and renders resistance to Hsp90 disruption.

Authors:  Yongfeng Shao; Bingchan Wang; Dorothy Shi; Suyu Miao; Panneerselvam Manivel; Ramadas Krishna; Yiding Chen; Y Eric Shi
Journal:  Mol Oncol       Date:  2014-06-14       Impact factor: 6.603

4.  Expression of ERα, its ERαΔ3 Splice Variant and γ-SYNUCLEIN in Ovarian Cancer: A Pilot Study.

Authors:  Karen T Cheung; Siân E Taylor; Imran I Patel; Adam J Bentley; Helen F Stringfellow; Nigel J Fullwood; Pierre L Martin-Hirsch; Francis L Martin
Journal:  Br J Med Med Res       Date:  2011-10

5.  Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.

Authors:  Stephanie Marchese; Elisabete Silva
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

Review 6.  The Role of ERα36 in Development and Tumor Malignancy.

Authors:  Charlène Thiebaut; Henri-Philippe Konan; Marie-Justine Guerquin; Amand Chesnel; Gabriel Livera; Muriel Le Romancer; Hélène Dumond
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

7.  A candidate molecular signature associated with tamoxifen failure in primary breast cancer.

Authors:  Julie A Vendrell; Katherine E Robertson; Patrice Ravel; Susan E Bray; Agathe Bajard; Colin A Purdie; Catherine Nguyen; Sirwan M Hadad; Ivan Bieche; Sylvie Chabaud; Thomas Bachelot; Alastair M Thompson; Pascale A Cohen
Journal:  Breast Cancer Res       Date:  2008-10-17       Impact factor: 6.466

8.  Gamma-synuclein is an adipocyte-neuron gene coordinately expressed with leptin and increased in human obesity.

Authors:  Pieter J Oort; Trina A Knotts; Michel Grino; Nadia Naour; Jean-Phillipe Bastard; Karine Clément; Natalia Ninkina; Vladimir L Buchman; Paska A Permana; Xunyi Luo; Guohua Pan; Tamara N Dunn; Sean H Adams
Journal:  J Nutr       Date:  2008-05       Impact factor: 4.798

9.  Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform.

Authors:  Kathrin Schaal; Marc Hirschfeld; Peter Bronsert; Hannah Füllgraf; Markus Jäger; Bettina Herde; Claudia Nöthling; Sebastian Mayer; Thalia Erbes; Elmar Stickeler
Journal:  Oncotarget       Date:  2015-09-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.